With our promising clinical stage pipeline, we have many development opportunities at hand. That’s why we plan to pursue a range of strategic partnerships and alliances. Our research and development programs have been funded thus far through private investments. As we look to advance and expand our clinical programs, we are positive about partnering opportunities that can enhance our pipeline and bring our products to patients more rapidly.
To learn more and discuss partnering opportunities, please contact James Breitmeyer at 858-434-1113.